Sold by: Sage Bionetworks
Open data
|
Deployed on AWS
The Mount Sinai PsychAD Study provides population-scale single-nucleus RNA
sequencing data from the dorsolateral prefrontal cortex of 1,494 postmortem
brain donors. The study encompasses more than 6.3 million nuclei from
individuals with neurodegenerative diseases, serious mental illnesses, and
neurotypical controls. Represented conditions include Alzheimer's disease,
Parkinson's disease, schizophrenia, bipolar disorder, diffuse Lewy body
dementia, vascular dementia, and additional neurological and psychiatric
disorders. The study also includes genotype, clinical, neuropathological, and
neuropsychiatric symptom data where available.
Overview
The Mount Sinai PsychAD Study provides population-scale single-nucleus RNA sequencing data from the dorsolateral prefrontal cortex of 1,494 postmortem brain donors. The study encompasses more than 6.3 million nuclei from individuals with neurodegenerative diseases, serious mental illnesses, and neurotypical controls. Represented conditions include Alzheimer's disease, Parkinson's disease, schizophrenia, bipolar disorder, diffuse Lewy body dementia, vascular dementia, and additional neurological and psychiatric disorders. The study also includes genotype, clinical, neuropathological, and neuropsychiatric symptom data where available.
Features and programs
Open Data Sponsorship Program
This dataset is part of the Open Data Sponsorship Program, an AWS program that covers the cost of storage for publicly available high-value cloud-optimized datasets.
Pricing
This is a publicly available data set. No subscription is required.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Open data resources
Available with or without an AWS account.
- How to use
- To access these resources, reference the Amazon Resource Name (ARN) using the AWS Command Line Interface (CLI). Learn more
- Description
- This study provides controlled-access genotype, single-nucleus RNA sequencing, clinical, neuropathological, neuropsychiatric symptom, and related metadata from 1,494 postmortem brain donors representing neurodegenerative diseases, serious mental illnesses, and neurotypical controls.
- Resource type
- S3 bucket
- Amazon Resource Name (ARN)
- arn:aws:s3:::mssm-psych-ad.opendata.sagebase.org
- AWS region
- us-east-1
- AWS CLI access (No AWS account required)
- aws s3 ls --no-sign-request s3://mssm-psych-ad.opendata.sagebase.org/
Resources
Vendor resources
Support
Managed By
Sage Bionetworks
How to cite
The Mount Sinai PsychAD Study (MSSM_PsychAD) was accessed on DATE from https://registry.opendata.aws/mssm-psych-ad .
Similar products
The Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) consortium strives to gain a deep molecular and cellular understanding of the early pathogenesis of Alzheimer's disease and is funded by the National Institutes on Aging (NIA U19AG060909). The SEA-AD datasets available here comprise single cell profiling (transcriptomics and epigenomics) and quantitative neuropathology. To explore gene expression and chromatin accessibility information, the single-cell profiling data includes: snRNAseq and snATAC-seq data from the SEA-AD donor cohort (aged brains which span the spectrum of Alzheimer's Disease pathology) and neurotypical reference brains. To explore key pathological proteins and cell types of interest to Alzheimer's disease, the neuropathology data includes: full resolution brightfield images, images processed and segmented in HALO image analysis software, image annotations, and quantification summary files for the relevant stains including Abeta (6E10), IBA1, a-Synuclein, G[...]
The Seattle Alzheimer's Disease Brain Cell Atlas Integrative Analysis Center
(SEA-AD IAC) reprocesses datasets from SEA-AD and other large-scale
Alzheimer's disease and related dementia studies to support harmonized
cross-study analyses. The study provides uniformly processed single-cell
genomics and multiomic data, harmonized metadata, and representations of
disease pathology mapped to highly annotated BRAIN Initiative Cell Atlas
Network (BICAN) and SEA-AD cell classifications. These resources support
investigation of cell-type-specific molecular changes across Alzheimer's
disease cohorts and stages of disease progression.
AdAdvisor by TransUnion's Propensity & Interests audiences cover everything from purchase behaviors to household net worth, beauty and personal care, pets, real estate, education, apparel, media consumption, and more. Reach your omnichannel consumers with thousands of propensity audiences spanning all verticals.
The Religious Orders Study (ROS) and Rush Memory and Aging Project (MAP) are
ongoing longitudinal clinical-pathologic cohort studies of aging and
Alzheimer's disease. Participants enroll without known dementia, undergo
annual clinical and cognitive evaluations, and agree to organ donation at
death. The ROSMAP study provides genomic, transcriptomic, epigenomic,
proteomic, metabolomic, imaging, and related metadata generated from these
cohorts to support research into cognitive decline, neuropathology, brain
aging, and the molecular mechanisms of Alzheimer's disease.